HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 291/5/F1090    most recent 00517.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (9) Citing Articles via Google Scholar Google Scholar Articles by Wang, W. Articles by Schrier, R. Search for Related Content PubMed PubMed Citation Articles by Wang, W. Articles by Schrier, R.

Pentoxifylline protects against endotoxin-induced acute renal failure in mice

Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado

Submitted 27 December 2005 ; accepted in final form 9 May 2006

Acute renal failure (ARF) in septic patients drastically increases the mortality to 50–80%. Sepsis induces several proinflammatory cytokines including tumor necrosis factor- (TNF-), a major pathogenetic factor in septic ARF. Pentoxifylline has several functions including downregulation of TNF- and endothelia-dependent vascular relaxation. We hypothesized that pentoxifylline may afford renal protection during endotoxemia either by downregulating TNF- and/or by improving endothelial function. In wild-type mice, pentoxifylline protected against the fall in glomerular filtration rate (GFR; 105.2 ± 6.6 vs. 50.2 ± 6.6 µl/min, P < 0.01) at 16 h of LPS administration (2.5 mg/kg ip). This renal protective effect of pentoxifylline was associated with an inhibition of the rise in serum TNF- (1.00 ± 0.55 vs. 7.02 ± 2.40 pg/ml, P < 0.05) and serum IL-1 (31.3 ± 3.6 vs. 53.3 ± 5.9 pg/ml, P < 0.01) induced by LPS. Pentoxifylline also reversed the LPS-related increase in renal iNOS and ICAM-1 and rise in serum nitric oxide (NO). Enhanced red blood cell deformability by pentoxifylline may have increased shear rate and upregulated eNOS. Studies were therefore performed in eNOS knockout mice. The renal protection against endotoxemia with pentoxifylline was again observed as assessed by GFR (119.8 ± 18.0 vs. 44.5 ± 16.2 µl/min, P < 0.05) and renal blood flow (0.86 ± 0.08 vs. 0.59 ± 0.05 ml/min, P < 0.05). Renal vascular resistance significantly decreased with the pentoxifylline (91.0 ± 5.8 vs. 178.0 ± 7.6 mmHg·ml^–1·min^–1, P < 0.01). Thus pentoxifylline, an FDA-approved drug, protects against endotoxemia-related ARF and involves a decrease in serum TNF-, IL-1, and NO as well as a decrease in renal iNOS and ICAM-1.

sepsis; tumor necrosis factor

This article has been cited by other articles:

				J A Leithead, J W Ferguson, C M Bates, J S Davidson, A Lee, A J Bathgate, P C Hayes, and K J Simpson The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure Gut, March 1, 2009; 58(3): 443 - 449. [Abstract] [Full Text] [PDF]

				Z. Zhou, P. Gengaro, W. Wang, X.-q. Wang, C. Li, S. Faubel, C. Rivard, and R. W. Schrier Role of NF-{kappa}B and PI 3-kinase/Akt in TNF-{alpha}-induced cytotoxicity in microvascular endothelial cells Am J Physiol Renal Physiol, October 1, 2008; 295(4): F932 - F941. [Abstract] [Full Text] [PDF]

				W. Wang, E. Zolty, S. Falk, S. Summer, Z. Zhou, P. Gengaro, S. Faubel, N. Alp, K. Channon, and R. Schrier Endotoxemia-related acute kidney injury in transgenic mice with endothelial overexpression of GTP cyclohydrolase-1 Am J Physiol Renal Physiol, March 1, 2008; 294(3): F571 - F576. [Abstract] [Full Text] [PDF]

				W. Wang, E. Zolty, S. Falk, S. Summer, R. Stearman, M. Geraci, and R. Schrier Prostacyclin in endotoxemia-induced acute kidney injury: cyclooxygenase inhibition and renal prostacyclin synthase transgenic mice Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1131 - F1136. [Abstract] [Full Text] [PDF]

				A. Mitra, S. Bansal, W. Wang, S. Falk, E. Zolty, and R. W. Schrier Erythropoietin ameliorates renal dysfunction during endotoxaemia Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2349 - 2353. [Abstract] [Full Text] [PDF]

				G. Ramesh, B. Zhang, S. Uematsu, S. Akira, and W. B. Reeves Endotoxin and cisplatin synergistically induce renal dysfunction and cytokine production in mice Am J Physiol Renal Physiol, July 1, 2007; 293(1): F325 - F332. [Abstract] [Full Text] [PDF]

				C. Schmidt, K. Hocherl, F. Schweda, A. Kurtz, and M. Bucher Regulation of Renal Sodium Transporters during Severe Inflammation J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1072 - 1083. [Abstract] [Full Text] [PDF]